Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

Notice of Special Interest: Development of Cryogenic or Other Long-term Preservation and Revival Methods for Drosophila and Zebrafish Genetic Stocks

(NOT-OD-19-089) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notice of Clarification Regarding the Submission of Biosketches for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"

(NOT-OD-19-091) National Institutes of Health

Notice of Availability of Administrative Supplements for Geospatial, Multilevel, and Contextual Approaches in Cancer Control and Population Sciences

(NOT-CA-19-029) National Cancer Institute

Notice of Availability of Administrative Supplements to Promote Data Sharing in Cancer Epidemiology Studies

(NOT-CA-19-031) National Cancer Institute

NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program

(NOT-GM-19-021)National Institute of General Medical Sciences

Notice of Special Interest: Availability of Administrative Supplements to INBRE Awards to Fund Research in Collaboration with COBRE or IDeA-CTR Awards

(NOT-GM-19-025) National Institute of General Medical Sciences

Notice of Special Interest: SEARCH: Stimulating Exploratory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)

(NOT-HL-19-677) National Heart, Lung, and Blood Institute

Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases

(NOT-HL-19-678) National Heart, Lung, and Blood Institute

Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations

(NOT-MD-19-001) National Heart, Lung, and Blood Institute

New Deadline for Proposals to Collaborate with the NIH Common Fund Regenerative Medicine Programs (RMP) Stem Cell Translation Laboratory (SCTL)

(NOT-RM-19-004) Office of Strategic Coordination (Common Fund)

Requests for Applications

Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)

(RFA-HL-20-003) National Heart, Lung, and Blood Institute

Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed) (RFA-HL-20-004) National Heart, Lung, and Blood Institute

BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional)

(RFA-HL-20-009) National Heart, Lung, and Blood Institute

(RFA-HL-20-010) National Heart, Lung, and Blood Institute